Neurological Disorders

Neurological disorders are defined as disorders that affect the brain, spine and nerves throughout the human body. It is either associated with CNS or PNS or both. Structural, biochemical or electrical abnormalities can cause a wide range of neurological problems which eventually might lead to different types of mild to severe neurological disorders.

Neurological disorders have different causes and symptoms. Most of them start or emerge during the early stage of life or maybe diagnosed at birth. The symptoms of Neurological disorders vary in each disorder. Congenital causes, gene abnormalities, metabolic disorders, prenatal causes, nutritional deficiencies, complications during childbirth, acquired causes, immune disorders, traumatic brain injury, and toxins are some of the causes of Neurological disorders.

Some neurological disorders are:

Parkinson's disease
Amyotrophic lateral sclerosis or ALS
Brain tumors
Epilepsy
Stroke
Peripheral Neuropathy
Key treatment methods of Neurological disorders:

Neuroimaging techniques to diagnose
Brain mapping
Cognitive therapy treatment
Pain management
Physiotherapy
Deep brain stimulation
There are various other methods to treat these lifelong neurological disorders.

Sub-tracks: 

• ALS
• Epilepsy
• Parkinson's Disease
• Brain Aneurysm
• Spinal Cord Tumor
• Memory Disorders
• Multiple Sclerosis
• Arteriovenous Malformation
• Headache
• Dural Arteriovenous Fistulae
• Stroke
• Brain Tumors
• Peripheral Neuropathy
• Post-Herpetic Neuralgia

Market Analysis: The global neurology market is expected to increase at a compound annual growth rate (CAGR) of 3.5 percent from $33.3 billion in 2019 to $39.4 billion in 2024. Anticholinergic, antiepileptic, antipsychotic, hypnotic & sedative, analgesics, antihypertensive, anticoagulants, and others are the drug types that make up the global neurological diseases treatment market. According to a study, an estimated 5.4 million Americans suffer from Alzheimer's disease, and someone in the United States acquires the condition every 68 seconds.Due to key driving factors such as increasing prevalence of neurological disorders, developing healthcare infrastructure, rising awareness associated with neurological diseases, which is fueling the rate of diagnosis, and mounting accessibility of modern treatments in developing countries such as China, India, and Indonesia, Asia Pacific was identified as the fastest growing region between 2021 and 2029. According to the report, the global market for neurological disease pharmaceuticals was worth US$ 70 billion in 2018 and is expected to grow at a CAGR of 5% from 2019 to 2027.